186 related articles for article (PubMed ID: 35650345)
1. Metastatic melanoma treated by immunotherapy: discovering prognostic markers from radiomics analysis of pretreatment CT with feature selection and classification.
Ungan G; Lavandier AF; Rouanet J; Hordonneau C; Chauveau B; Pereira B; Boyer L; Garcier JM; Mansard S; Bartoli A; Magnin B
Int J Comput Assist Radiol Surg; 2022 Oct; 17(10):1867-1877. PubMed ID: 35650345
[TBL] [Abstract][Full Text] [Related]
2. Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab.
Durot C; Mulé S; Soyer P; Marchal A; Grange F; Hoeffel C
Eur Radiol; 2019 Jun; 29(6):3183-3191. PubMed ID: 30645669
[TBL] [Abstract][Full Text] [Related]
3. Baseline clinical and imaging predictors of treatment response and overall survival of patients with metastatic melanoma undergoing immunotherapy.
Schraag A; Klumpp B; Afat S; Gatidis S; Nikolaou K; Eigentler TK; Othman AE
Eur J Radiol; 2019 Dec; 121():108688. PubMed ID: 31704599
[TBL] [Abstract][Full Text] [Related]
4. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
[TBL] [Abstract][Full Text] [Related]
5. Machine learning-based CT texture analysis to predict HPV status in oropharyngeal squamous cell carcinoma: comparison of 2D and 3D segmentation.
Ren J; Yuan Y; Qi M; Tao X
Eur Radiol; 2020 Dec; 30(12):6858-6866. PubMed ID: 32591885
[TBL] [Abstract][Full Text] [Related]
6. CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy.
Lin Q; Wu HJ; Song QS; Tang YK
Front Oncol; 2022; 12():937277. PubMed ID: 36267975
[TBL] [Abstract][Full Text] [Related]
7. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
[TBL] [Abstract][Full Text] [Related]
8. A Machine learning model trained on dual-energy CT radiomics significantly improves immunotherapy response prediction for patients with stage IV melanoma.
Brendlin AS; Peisen F; Almansour H; Afat S; Eigentler T; Amaral T; Faby S; Calvarons AF; Nikolaou K; Othman AE
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34795006
[TBL] [Abstract][Full Text] [Related]
9. Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach.
Guerrisi A; Russillo M; Loi E; Ganeshan B; Ungania S; Desiderio F; Bruzzaniti V; Falcone I; Renna D; Ferraresi V; Caterino M; Solivetti FM; Cognetti F; Morrone A
Front Oncol; 2021; 11():704607. PubMed ID: 34692481
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Cross-Combinations of Feature Selection and Machine-Learning Classification Methods Based on [
Gómez OV; Herraiz JL; Udías JM; Haug A; Papp L; Cioni D; Neri E
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740588
[TBL] [Abstract][Full Text] [Related]
11. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
Peng L; Hong X; Yuan Q; Lu L; Wang Q; Chen W
Ann Nucl Med; 2021 Apr; 35(4):458-468. PubMed ID: 33543393
[TBL] [Abstract][Full Text] [Related]
12. Use of radiomics based on
Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
[TBL] [Abstract][Full Text] [Related]
13. Screening of COVID-19 based on the extracted radiomics features from chest CT images.
Rezaeijo SM; Abedi-Firouzjah R; Ghorvei M; Sarnameh S
J Xray Sci Technol; 2021; 29(2):229-243. PubMed ID: 33612539
[TBL] [Abstract][Full Text] [Related]
14. Multiclassifier fusion based on radiomics features for the prediction of benign and malignant primary pulmonary solid nodules.
Shen Y; Xu F; Zhu W; Hu H; Chen T; Li Q
Ann Transl Med; 2020 Mar; 8(5):171. PubMed ID: 32309318
[TBL] [Abstract][Full Text] [Related]
15. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
[TBL] [Abstract][Full Text] [Related]
16. CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma.
Ter Maat LS; van Duin IAJ; Elias SG; Leiner T; Verhoeff JJC; Arntz ERAN; Troenokarso MF; Blokx WAM; Isgum I; de Wit GA; van den Berkmortel FWPJ; Boers-Sonderen MJ; Boomsma MF; van den Eertwegh FJM; de Groot JWB; Piersma D; Vreugdenhil A; Westgeest HM; Kapiteijn E; van Diest PJ; Pluim JPW; de Jong PA; Suijkerbuijk KPM; Veta M
Eur J Cancer; 2023 May; 185():167-177. PubMed ID: 36996627
[TBL] [Abstract][Full Text] [Related]
17. Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy.
Sun R; Lerousseau M; Briend-Diop J; Routier E; Roy S; Henry T; Ka K; Jiang R; Temar N; Carré A; Laville A; Hamaoui A; Laurent PA; Rouyar A; Robert C; Robert C; Deutsch E
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36307149
[TBL] [Abstract][Full Text] [Related]
18. Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC.
Bouhamama A; Leporq B; Faraz K; Foy JP; Boussageon M; Pérol M; Ortiz-Cuaran S; Ghiringhelli F; Saintigny P; Beuf O; Pilleul F
Front Radiol; 2023; 3():1168448. PubMed ID: 37492391
[TBL] [Abstract][Full Text] [Related]
19. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
20. Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma.
Park KJ; Lee JL; Yoon SK; Heo C; Park BW; Kim JK
Eur Radiol; 2020 Oct; 30(10):5392-5403. PubMed ID: 32394281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
